Approvals/CIMA-AEMPS/COMIRNATY OMICRON XBB.1.5 (3 MICROGRAMOS/DOSIS) CONCENTRADO PARA DISPERSION INYECTABLE

Approved

STANDARD

COMIRNATY OMICRON XBB.1.5 (3 MICROGRAMOS/DOSIS) CONCENTRADO PARA DISPERSION INYECTABLE

Biontech Manufacturing Gmbh🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: de6cac66f0a36c8e
Drug Cima Aemps Name: COMIRNATY OMICRON XBB.1.5 (3 MICROGRAMOS/DOSIS) CONCENTRADO PARA DISPERSION INYECTABLE
Register Number: 1201528024
Holder Company Name: Biontech Manufacturing Gmbh
Marketing Company Name: Pfizer S.L.
Holder Company Detail Path: /organization/biontech-manufacturing-gmbh
Authorization Date: 2023-09-04
Dosage Form: CONCENTRADO PARA DISPERSION INYECTABLE
Dose: 3 MICROGRAMOS/DOSIS
Route Of Administration: VÍA INTRAMUSCULAR
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Biontech Manufacturing Gmbh
Company Detail Path: /organization/biontech-manufacturing-gmbh

RAXTOZINAMERAN

0,015 mg/ml

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Sep 4, 2023

Approval ID

de6cac66f0a36c8e

Type

Standard